Orthofix Medical’s (OFIX) “Outperform” Rating Reiterated at Barrington Research

Barrington Research restated their outperform rating on shares of Orthofix Medical (NASDAQ:OFIX) in a report published on Thursday,Benzinga reports. They currently have a $17.00 price objective on the medical device company’s stock.

Other equities research analysts also recently issued research reports about the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Orthofix Medical in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Orthofix Medical from a “sell” rating to a “hold” rating in a report on Saturday, August 9th. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, Orthofix Medical presently has an average rating of “Moderate Buy” and an average price target of $21.75.

Orthofix Medical Stock Up 0.3%

Shares of NASDAQ:OFIX opened at $15.97 on Thursday. Orthofix Medical has a 52 week low of $10.24 and a 52 week high of $20.73. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.50 and a current ratio of 2.67. The company has a market capitalization of $630.66 million, a PE ratio of -5.04 and a beta of 0.89. The company has a 50 day moving average price of $14.77 and a two-hundred day moving average price of $12.93.

Orthofix Medical (NASDAQ:OFIX) last issued its earnings results on Tuesday, August 5th. The medical device company reported ($0.36) EPS for the quarter, missing the consensus estimate of $0.04 by ($0.40). Orthofix Medical had a negative net margin of 15.29% and a negative return on equity of 25.43%. The firm had revenue of $203.12 million during the quarter, compared to the consensus estimate of $196.89 million. Orthofix Medical has set its FY 2025 guidance at EPS. Analysts forecast that Orthofix Medical will post -2.81 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. CWM LLC boosted its holdings in Orthofix Medical by 99.0% during the third quarter. CWM LLC now owns 1,920 shares of the medical device company’s stock worth $28,000 after purchasing an additional 955 shares during the last quarter. State of Alaska Department of Revenue acquired a new position in Orthofix Medical during the third quarter worth $30,000. US Bancorp DE boosted its holdings in Orthofix Medical by 684.6% during the first quarter. US Bancorp DE now owns 5,673 shares of the medical device company’s stock worth $93,000 after purchasing an additional 4,950 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Orthofix Medical during the second quarter worth $147,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management boosted its holdings in Orthofix Medical by 32.6% during the second quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 13,297 shares of the medical device company’s stock worth $148,000 after purchasing an additional 3,271 shares during the last quarter. Institutional investors and hedge funds own 89.76% of the company’s stock.

About Orthofix Medical

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.